BEYONDSPRING INC.

BYSI
Delayed Quote. Delayed  - 10/23 04:00:00 pm
14.83USD +5.03%
Prev.14.1200
Open14.0500
High15.5000
Low13.7200
Volume191 228
Latest news
10/14
10/12
09/29
09/24
Chart BEYONDSPRING INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralNeutralNeutral
Resistance15,618,218,5
Spread/Res.-5,1%-18%-20%
Spread/Supp.18%48%43%
Support12,69,9910,4
Financials
Sales 2020 - - -
Net income 2020 -60,7 M - -
Net Debt 2020 - - -
P/E ratio 2020 -7,13x
Yield 2020 -
Capitalization 447 M 447 M -
Capi. / Sales 2020 -
Capi. / Sales 2021 30,9x
Nbr of Employees 61
Free-Float 12,0%
Company
BeyondSpring Inc. is a global clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of immuno-oncology cancer therapies. The Company’s lead product Plinabulin, is being studied in late-stage clinical trials as an anti-cancer agent in combination...

>> Read more
Sector :
Bio Therapeutic Drugs
Calendar :
2020-11-05 Earnings Release
Trading Rating :
Investor Rating : -

Income Statement Evolution
Consensus
Mean consensus BUY
Number of Analysts 3
Average target price 41,50 $
Last Close Price 14,83 $
Spread / Highest target 210%
Spread / Average Target 180%
Spread / Lowest Target 149%